Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the human genome.

Kiyoshi Tachikawa1, Steven P Briggs

  • 1Section of Cell and Developmental Biology, University of California at San Diego, La Jolla, CA 92093, USA.

Current Opinion in Biotechnology
|November 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials.

Advanced healthcare materials·2026
Same author

An increase of <i>NPY1</i> expression leads to inhibitory phosphorylation of PIN-FORMED (PIN) proteins and suppression of <i>pinoid</i> (<i>pid</i>) null mutants.

eLife·2025
Same author

A multifunctional sesquiterpene synthase integrates with cytochrome P450s to reinforce the terpenoid defense network in maize.

The Plant journal : for cell and molecular biology·2025
Same author

A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.

Molecular therapy. Nucleic acids·2024
Same author

Nuclear pyruvate dehydrogenase complex regulates histone acetylation and transcriptional regulation in the ethylene response.

Science advances·2024
Same author

Suppression of <i>pinoid</i> mutant phenotypes by mutations in <i>PIN-FORMED 1</i> and PIN1-GFP fusion.

Proceedings of the National Academy of Sciences of the United States of America·2023

Artificially designed transcription factors offer a promising alternative to nucleic-acid-based gene expression tools. These novel molecules provide high specificity and can modify genomes, overcoming limitations of current gene-targeting technologies.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Biotechnology

Background:

  • Nucleic-acid-based tools like antisense oligonucleotides and small interfering RNA have limitations in delivery efficiency and target specificity.
  • Existing gene-targeting methods often fall short for various therapeutic and research applications.

Purpose of the Study:

  • To introduce artificially designed transcription factors as a superior alternative for gene expression modulation and genome modification.
  • To highlight the potential of these novel molecules in overcoming the in vivo delivery and specificity challenges.

Main Methods:

  • Development of artificial transcription factors capable of recognizing specific DNA sequences.
  • Engineering these factors for roles as transcriptional regulators and genome modifiers (cleavage, mutation induction).

Related Experiment Videos

  • Investigation of delivery technologies to enhance cellular uptake and therapeutic efficacy.

    • Main Results:

    • Artificial transcription factors demonstrate high specificity for target DNA sequences.
    • These engineered proteins function as versatile tools for both gene regulation and precise genome editing.
    • Advancements in delivery technologies are crucial for realizing the therapeutic potential of these nucleotide-targeting molecules.

    Conclusions:

    • Artificially designed transcription factors represent a significant advancement in gene-targeting technologies.
    • Their high specificity and dual functionality offer solutions to limitations of current nucleic-acid-based tools.
    • Efficient delivery systems are key to translating the therapeutic promise of these innovative molecules.